Although there are currently no studies reporting the mechanisms by which LCP1 regulates the immune system, one study indicates that its family member, LCP2, participates in the activation of TCR signaling and indirectly influences TCR signaling through CD28 and the B7 family, thereby modulating anti-tumor immunity response [54]. The gene discussed is LCP1; the disease is neoplasm.